Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Single-blinded (Evaluator), 3-treatment Arm, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of CDFR0612 and CDFR0613

NCT02304523 is registered in ClinicalTrials.gov with CTC Bio, Inc. as lead sponsor.

NCT NCT02304523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02304523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Single-blinded (Evaluator), 3-treatment Arm, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of CDFR0612 and CDFR0613
Lead sponsor
CTC Bio, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2015
Completion date
September 30, 2015
Enrollment
310 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colon disease, colonoscopy preparation